60 Degrees Pharmaceuticals, Inc.
SXTP
$0.95
-$0.02-2.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 28.25% | -48.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 28.25% | -48.77% | |||
| Cost of Revenue | 104.19% | -51.66% | |||
| Gross Profit | -164.21% | 53.72% | |||
| SG&A Expenses | -8.50% | 28.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.83% | 1.05% | |||
| Operating Income | -8.41% | -9.26% | |||
| Income Before Tax | -8.39% | -45.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.39% | -45.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 22.22% | 80.00% | |||
| Net Income | -8.39% | -45.22% | |||
| EBIT | -8.41% | -9.26% | |||
| EBITDA | -8.27% | -9.26% | |||
| EPS Basic | 29.56% | 12.66% | |||
| Normalized Basic EPS | 29.51% | 10.39% | |||
| EPS Diluted | 29.56% | 12.66% | |||
| Normalized Diluted EPS | 29.51% | 10.39% | |||
| Average Basic Shares Outstanding | 53.77% | 61.85% | |||
| Average Diluted Shares Outstanding | 53.77% | 61.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||